Cited by 127Cell Adhesion Molecules ResearchImmune cells in cancerAngiogenesis and VEGF in Cancer

Integrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors

Jin, Hui, Su, Jingmei, Garmy-Susini, Barbara, Kleeman, Jeanine, Varner, Judy·2006·Cancer Research

Published version of a preprint

Abstract

Monocytes and macrophages extensively colonize solid tumors, where they are thought to promote tumor angiogenesis. Here, we show that integrin alpha4beta1 (VLA4) promotes the invasion of tumors by myeloid cells and subsequent neovascularization. Antagonists of integrin alpha4beta1, but not of other integrins, blocked the adhesion of monocytes to endothelium in vitro and in vivo as well as their extravasation into tumor tissue. These antagonists prevented monocyte stimulation of angiogenesis in vivo, macrophage colonization of tumors, and tumor angiogenesis. These studies indicate the usefulness of antagonists of integrin alpha4beta1 in suppressing macrophage colonization of tumors and subsequent tumor angiogenesis. These studies further indicate that suppression of myeloid cell homing to tumors could be a useful supplementary approach to suppress tumor angiogenesis and growth.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-05-2704

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • α4β1/αvβ3 integrins are expressed in hematopoietic and endothelial cells and play a key role in inflammation.

    “The α4β1/αvβ3 integrins are expressed in hematopoietic and endothelial cells [14] and play a key role in inflammation [15], [29], [46], [47].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jin, H., Su, J., Garmy-Susini, B., Kleeman, J., & Varner, J.
Affiliations
  • University of California San Diego (US)
  • 1John and Rebecca Moores Comprehensive Cancer Center and
Venue
Cancer Research
Published
2006-02-15
Volume
66
Issue
4
Pages
2146-2152
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2089929639
Cited by
127
References
1
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 12 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 8 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 5 · 2012: 5
FWCI
8.45
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
alpha4beta1 integrin, VLA-4, monocyte trafficking, tumor angiogenesis, tumor-associated macrophages, integrin antagonists, extravasation, neovascularization, tumor invasion
MeSH terms
Animals, Cell Adhesion, Colonic Neoplasms, Humans, Leukocytes, Mononuclear, Macrophages, Mice, Nude, Neovascularization, Pathologic, Carcinoma, Lewis Lung, HT29 Cells, Myeloid Cells, Integrin alpha4beta1, Lymphangiogenesis, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review